Loading...

Medica Group Plc

MGP.L•LSE
HealthcareMedical - Devices
$212.00
$1.00(0.47%)

Medica Group Plc (MGP.L) Stock Overview

Explore Medica Group Plc’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for MGP.LStats details for MGP.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MGP.LAnalyst Recommendations details for MGP.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Medica Group Plc, together with its subsidiaries, provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom, Ireland, and the United States. It offers NightHawk, an out-of-hours service, which provides emergency reporting services through radiologists for stroke and major trauma; cardiac, computerized tomography (CT) colonography, PET CT and nuclear medicine, CT Cone Beam, DEXA, audit, and MR prostate services; AI powered CT Brain solution for detection of intracranial haemorrhage to acute teleradiology reporting workflow; and elective scanning services. The company also provides routine plain film and radiographer plain film services, and managed services, as well as ophthalmology services and various imaging lab services. Medica Group Plc was founded in 2004 and is headquartered in Hastings, the United Kingdom.

CEO

Dr. Stuart Quin Ph.D.

Employees

222

Headquarters

One Priory Square, Hastings

Founded

2017

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.